217448-86-7: Rufinamide Related Compound B
Rufinamide Related Compound B ( CAS No: 217448-86-7 ) or Methyl 1-(2,6-Difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate is Associate in Nursing impurity of Rufinamide. Rufinamide oral suspension may be a medicament used with different medicines to treat seizures related to Lennox-Gastaut Syndrome (LGS) in adults and medical specialty patients one year archaic and older.
Additional information on CAS 217448-86-7
Catalogue No.
VL3000002
CAS No.
217448-86-7
Molecular Formula
C11H9F2N3O2
Molecular Weight
253.06
Parent drug
Rufinamide
IUPAC Name
Methyl 1-(2, 6-Difluorobenzyl)-1H-1, 2, 3-triazole-4-carboxylate
Synonyms
Rufinamide Methyl Ester Analog / Rufinamide 4-Descarboxamido 4-Methyl Ester
References
“Sci-Hub, Rufinamide, 10.2165/00023210-200620090-00007.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.2165/00023210-200620090-00007.
Status
In-stock
